Objective:

To characterize the chemical signatures of pathological tau protein across various neurodegenerative diseases and improve diagnostics and treatment strategies.

Key Findings:

• 145 post-translational modifications and 195 cleavage sites were mapped across tau.
• Each tauopathy is defined by a unique combination of modifications and cleavage patterns.
• Machine learning analysis provided a priority list for diagnostics and drug development based on modification importance.

Interpretation:

The study provides a precise molecular roadmap for targeting specific tau modifications in diagnostics and therapeutic development, moving away from a generalized approach.

Limitations:

• Study focused on post-mortem brain tissue, which may not fully represent in vivo conditions.
• Findings may not be generalizable across all tauopathies or populations.

Conclusion:

This research advances the understanding of tau-related diseases and offers a framework for developing targeted diagnostics and therapies.